395 related articles for article (PubMed ID: 28458337)
61. Symptomatic Hypokalemia in a 19-Year-Old Student.
Pereira S; Salgueiro A; Rosa P; Peixoto C; Ferreira M; Silva D
Acta Medica (Hradec Kralove); 2020; 63(3):137-140. PubMed ID: 33002402
[TBL] [Abstract][Full Text] [Related]
62. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
[TBL] [Abstract][Full Text] [Related]
63. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.
Wu VC; Chueh SJ; Chen L; Chang CH; Hu YH; Lin YH; Wu KD; Yang WS;
J Hypertens; 2017 Aug; 35(8):1698-1708. PubMed ID: 28661412
[TBL] [Abstract][Full Text] [Related]
64. Systematic review of surgery and outcomes in patients with primary aldosteronism.
Muth A; Ragnarsson O; Johannsson G; Wängberg B
Br J Surg; 2015 Mar; 102(4):307-17. PubMed ID: 25605481
[TBL] [Abstract][Full Text] [Related]
65. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy.
Riester A; Reincke M
Eur J Endocrinol; 2015 Jan; 172(1):R23-30. PubMed ID: 25163723
[TBL] [Abstract][Full Text] [Related]
66. Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism.
Catena C; Colussi G; Di Fabio A; Valeri M; Marzano L; Uzzau A; Sechi LA
Horm Metab Res; 2010 Jun; 42(6):440-5. PubMed ID: 20119883
[TBL] [Abstract][Full Text] [Related]
67. Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment.
Sechi LA; Colussi G; Di Fabio A; Catena C
Am J Hypertens; 2010 Dec; 23(12):1253-60. PubMed ID: 20706195
[TBL] [Abstract][Full Text] [Related]
68. Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma.
Giacchetti G; Ronconi V; Rilli S; Guerrieri M; Turchi F; Boscaro M
Eur J Endocrinol; 2009 Apr; 160(4):639-46. PubMed ID: 19131503
[TBL] [Abstract][Full Text] [Related]
69. Effects of Treating Primary Aldosteronism on Renal Function.
Kramers BJ; Kramers C; Lenders JW; Deinum J
J Clin Hypertens (Greenwich); 2017 Mar; 19(3):290-295. PubMed ID: 27659389
[TBL] [Abstract][Full Text] [Related]
70. Factors determining cardiovascular and renal outcomes after adrenalectomy in patients with aldosterone-producing adrenal adenoma.
Chiou TT; Chiang PH; Fuh M; Liu RT; Lee WC; Lee WC; Ng HY; Tsai YC; Chuang FR; Huang CC; Lee CT
Tohoku J Exp Med; 2009 May; 218(1):17-24. PubMed ID: 19398869
[TBL] [Abstract][Full Text] [Related]
71. Unilateral Adrenalectomy for Primary Aldosteronism Due to Bilateral Adrenal Disease Can Result in Resolution of Hypokalemia and Amelioration of Hypertension.
Szabo Yamashita T; Shariq OA; Foster TR; Lyden ML; Dy BM; Young WF; Bancos I; McKenzie TJ
World J Surg; 2023 Feb; 47(2):314-318. PubMed ID: 36207420
[TBL] [Abstract][Full Text] [Related]
72. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
[TBL] [Abstract][Full Text] [Related]
73. Long-term results of surgical and conservative treatment of patients with primary aldosteronism.
Horký K; Widimský J; Hradec E; Gregorová I; Hradec M
Exp Clin Endocrinol; 1987 Dec; 90(3):337-46. PubMed ID: 3450533
[TBL] [Abstract][Full Text] [Related]
74. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
[TBL] [Abstract][Full Text] [Related]
75. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
Young WF
Endocrinology; 2003 Jun; 144(6):2208-13. PubMed ID: 12746276
[TBL] [Abstract][Full Text] [Related]
76. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist.
Vardeny O; Claggett B; Anand I; Rossignol P; Desai AS; Zannad F; Pitt B; Solomon SD;
Circ Heart Fail; 2014 Jul; 7(4):573-9. PubMed ID: 24812304
[TBL] [Abstract][Full Text] [Related]
77. Renal Function Evolution and Hypoaldosteronism Risk After Unilateral Adrenalectomy for Primary Aldosteronism.
Queiroz NL; Stumpf MAM; Souza VCM; Maciel AAW; Fagundes GFC; Okubo J; Srougi V; Tanno FY; Chambo JL; Pereira MAA; Pio-Abreu A; Bortolotto LA; Latronico AC; Barisson Villares Fragoso MC; Drager LF; Mendonça BB; Almeida MQ
Horm Metab Res; 2024 May; 56(5):350-357. PubMed ID: 38040032
[TBL] [Abstract][Full Text] [Related]
78. Long term outcome of Aldosteronism after target treatments.
Wu VC; Wang SM; Chang CH; Hu YH; Lin LY; Lin YH; Chueh SC; Chen L; Wu KD
Sci Rep; 2016 Sep; 6():32103. PubMed ID: 27586402
[TBL] [Abstract][Full Text] [Related]
79. Primary aldosteronism. Results of surgical treatment.
Lo CY; Tam PC; Kung AW; Lam KS; Wong J
Ann Surg; 1996 Aug; 224(2):125-30. PubMed ID: 8757374
[TBL] [Abstract][Full Text] [Related]
80. Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea.
Wang E; Chomsky-Higgins K; Chen Y; Nwaogu I; Seib CD; Shen WT; Duh QY; Suh I
J Surg Res; 2019 Apr; 236():37-43. PubMed ID: 30694777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
